Sujay Kango

Chief Executive Officer, Avantogen Oncology, Inc.

Companies

Magenta TherapeuticsBoard member Mar 5, 2025 to now¹
Lite Strategy, Inc.Board member Nov 23, 2021 to Oct 12, 2023²
INFINITY PHARMACEUTICALS, INC.Board member Mar 31, 2022 to Mar 31, 2022³
Acceleron PharmaSVP, Chief Commercial Officer Feb 13, 2018 to Nov 22, 2021⁴
INFINITY PHARMACEUTICALS, INC.Chief Commercial Officer Apr 1, 2015 to Dec 14, 2016⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lite Strategy, Inc. LITS0 shares⁶Nov 23, 2021
Acceleron Pharma XLRN0 shares⁷Nov 19, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 19, 2021U 18,509 shares of Acceleron Pharma⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMagenta Therapeutics, Board member
2
SEC EDGARLite Strategy, Inc., Board member
3
SEC EDGARINFINITY PHARMACEUTICALS, INC., Board member
4
SEC EDGARAcceleron Pharma, SVP, Chief Commercial Officer
5
SEC EDGARINFINITY PHARMACEUTICALS, INC., Chief Commercial Officer
6
SEC EDGARLite Strategy, Inc. shares after the filing of Nov 23, 2021
7
SEC EDGARAcceleron Pharma shares after the filing of Nov 19, 2021